Acute blockade of corticosterone secretion decreases the psychomotor stimulant effects of cocaine. 1997

M Marinelli, and F Rougé-Pont, and C De Jesus-Oliveira, and M Le Moal, and P V Piazza
Department of Adaptive Behavioral Psychobiology, INSERM U 259, University of Bordeaux II, France.

Previous reports have shown that long-term blockade of corticosterone secretion, by either adrenalectomy or repeated treatment with an inhibitor of corticosterone synthesis, metyrapone, profoundly reduces sensitivity to drugs of abuse. In this report we investigated whether acute blockade of corticosterone secretion has similar effects. Animals received a single injection of metyrapone (50 mg/kg SC) and were tested for their locomotor response to cocaine (15 mg/kg IP) 3 hours later. Acute metyrapone treatment reduced the locomotor response to cocaine by about 50%, and this effect was reversed by corticosterone (20 mg/kg SC). The behavioral effects of these treatments paralleled changes in plasma corticosterone levels 20 minutes after an injection of cocaine. Despite the differences in behavior and corticosterone levels, the brain levels of cocaine in these groups did not differ. These results indicate that the behavioral effects of cocaine can be modified by an acute pharmacological manipulation of corticosterone secretion.

UI MeSH Term Description Entries
D008124 Locomotion Movement or the ability to move from one place or another. It can refer to humans, vertebrate or invertebrate animals, and microorganisms. Locomotor Activity,Activities, Locomotor,Activity, Locomotor,Locomotor Activities
D008297 Male Males
D008797 Metyrapone An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME. Methbipyranone,Methopyrapone,Metopiron,Metopirone,Métopirone,SU 4885
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D003042 Cocaine An alkaloid ester extracted from the leaves of plants including coca. It is a local anesthetic and vasoconstrictor and is clinically used for that purpose, particularly in the eye, ear, nose, and throat. It also has powerful central nervous system effects similar to the amphetamines and is a drug of abuse. Cocaine, like amphetamines, acts by multiple mechanisms on brain catecholaminergic neurons; the mechanism of its reinforcing effects is thought to involve inhibition of dopamine uptake. Cocaine HCl,Cocaine Hydrochloride,HCl, Cocaine,Hydrochloride, Cocaine
D003345 Corticosterone An adrenocortical steroid that has modest but significant activities as a mineralocorticoid and a glucocorticoid. (From Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1437)
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

M Marinelli, and F Rougé-Pont, and C De Jesus-Oliveira, and M Le Moal, and P V Piazza
June 1992, Annals of the New York Academy of Sciences,
M Marinelli, and F Rougé-Pont, and C De Jesus-Oliveira, and M Le Moal, and P V Piazza
October 2011, Experimental and clinical psychopharmacology,
M Marinelli, and F Rougé-Pont, and C De Jesus-Oliveira, and M Le Moal, and P V Piazza
May 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience,
M Marinelli, and F Rougé-Pont, and C De Jesus-Oliveira, and M Le Moal, and P V Piazza
June 1996, Brain research,
M Marinelli, and F Rougé-Pont, and C De Jesus-Oliveira, and M Le Moal, and P V Piazza
December 1995, Psychopharmacology,
M Marinelli, and F Rougé-Pont, and C De Jesus-Oliveira, and M Le Moal, and P V Piazza
November 1999, Psychopharmacology,
M Marinelli, and F Rougé-Pont, and C De Jesus-Oliveira, and M Le Moal, and P V Piazza
October 1995, Progress in neuro-psychopharmacology & biological psychiatry,
M Marinelli, and F Rougé-Pont, and C De Jesus-Oliveira, and M Le Moal, and P V Piazza
January 1988, NIDA research monograph,
M Marinelli, and F Rougé-Pont, and C De Jesus-Oliveira, and M Le Moal, and P V Piazza
January 1993, Life sciences,
M Marinelli, and F Rougé-Pont, and C De Jesus-Oliveira, and M Le Moal, and P V Piazza
January 1993, NIDA research monograph,
Copied contents to your clipboard!